“…Rhodanine-3-acetic acid (RAA) was prepared by Körner [ 2 ] in 1908, and condensation products of the acid with various aldehydes were reported in the same year [ 3 ]. Since that time, many (5-arylalkylidene-4-oxo-2-thioxo-1,3-thiazolidin-3-yl)alkanoic acids have been prepared and studied as potential antimycobacterial [ 4 , 5 ], antifungal [ 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 ], pesticidal [ 16 , 17 , 18 ], antihypertensive [ 19 ], and antineoplastic [ 20 , 21 ] agents. Rhodanine carboxylic acid derivatives have also be patented for the treatment and prevention of metabolic bone disorders.…”